NANTAHALA CAPITAL MANAGEMENT LLC
Q3 2026 Form 13-F
NEW CANAAN, CONNECTICUT
CIK 0001472322
· CRD 158081
· SEC-registered investment adviser
$3.2B Reported Value Total
NANTAHALA CAPITAL MANAGEMENT, LLC reports 11 total accounts under management (AUM). There are 11 discretionary accounts valued at $3,114,082,769, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
12 funds
· $3.0B gross asset value
Hedge Fund: $3.0B
Source: Form ADV filed 2026-09-14
Reported value
$3.2B
Quarter over quarter
-3.4%
Holdings
143
Top-10 concentration
37.4%
Key People
Form ADV owners & control persons
Steven Harris Bloom
MANAGER
Wilmot B. Harkey
MANAGING MEMBER
Daniel J. Mack
MANAGING MEMBER
Filing Navigation
Coverage begins with the second quarter of 2013. Earlier quarters are not shown while their accuracy is being verified.
13F Metrics
Loading 13F Metrics
Q3 2026 13F record
Q3 2026 13F filing summary
| Period of report | September 30, 2026 |
|---|---|
| Filed | November 13, 2026 |
| Form | 13F-HR |
| Reported value | $3.2B |
| Positions | 143 |
| Change in reported value | +4.9% |
| New positions | 32 |
| Exited positions | 20 |
| Position turnover | 31.9% |
| Top-10 concentration | 37.4% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 13, 2026
|
143 | $3.2B |
|
Q2 2026 13F
Filed Aug 14, 2026
|
131 | $3.0B |
|
Q1 2026 13F
Filed May 15, 2026
|
129 | $2.7B |
|
Q4 2025 13F
Filed Feb 13, 2026
|
132 | $3.0B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
131 | $2.9B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
138 | $2.6B |
|
Q1 2025 13F
Filed May 15, 2025
|
129 | $2.5B |
|
Q4 2024 13F
Filed Feb 14, 2025
|
122 | $2.3B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
124 | $2.0B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
116 | $1.7B |
|
Q1 2024 13F
Filed May 15, 2024
|
110 | $1.8B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
109 | $1.7B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
112 | $1.2B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
108 | $1.0B |
|
Q1 2023 13F
Filed May 15, 2023
|
109 | $1.3B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
103 | $1.5B |
|
Q3 2022 13F
Filed Nov 10, 2022
|
102 | $1.5B |
|
Q2 2022 13F
Filed Aug 15, 2022
|
104 | $2.0B |
|
Q1 2022 13F
Filed May 13, 2022
|
105 | $2.3B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
107 | $2.8B |
34 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q3 2026
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | IWM P ISHARES TR | $500.2M | 15.82% |
| 2 | XBI P SPDR SERIES TRUST | $110.4M | 3.49% |
| 3 | VTRS C VIATRIS INC | $88.6M | 2.8% |
| 4 | BVS BIOVENTUS INC | $87.5M | 2.77% |
| 5 | PTON C PELOTON INTERACTIVE INC | $85.2M | 2.69% |
| 6 | TBBK BANCORP INC DEL | $70.6M | 2.23% |
| 7 | KRE P SPDR SERIES TRUST | $69.4M | 2.2% |
| 8 | EW P EDWARDS LIFESCIENCES CORP | $69.1M | 2.18% |
| 9 | HLF C HERBALIFE LTD | $52.2M | 1.65% |
| 10 | EOLS EVOLUS INC | $50.0M | 1.58% |
| 11 | PTON PELOTON INTERACTIVE INC | $45.1M | 1.43% |
| 12 | ETON ETON PHARMACEUTICALS INC | $45.1M | 1.43% |
| 13 | HGV HILTON GRAND VACATIONS INC | $44.2M | 1.4% |
| 14 | AMRX AMNEAL PHARMACEUTICALS INC | $42.6M | 1.35% |
| 15 | LBRX LB PHARMACEUTICALS INC | $41.2M | 1.3% |
| 16 | PRAX P PRAXIS PRECISION MEDICINES I | $40.9M | 1.29% |
| 17 | HGV C HILTON GRAND VACATIONS INC | $40.7M | 1.29% |
| 18 | RARE C ULTRAGENYX PHARMACEUTICAL IN | $37.6M | 1.19% |
| 19 | SVRA SAVARA INC | $36.8M | 1.16% |
| 20 | FOSL FOSSIL GROUP INC | $36.2M | 1.14% |
Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.